In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation
© 2020 The American Society of Gene and Cell Therapy Synthetic mRNA therapeutics have the potential to revolutionize healthcare, as they enable patients to produce therapeutic proteins inside their own bodies. However, convenient methods that allow external control over the timing and magnitude of p...
Main Authors: | Mc Cafferty, Sean, De Temmerman, Joyca, Kitada, Tasuku, Becraft, Jacob R, Weiss, Ron, Irvine, Darrell J, Devreese, Mathias, De Baere, Siegrid, Combes, Francis, Sanders, Niek N |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2023
|
Online Access: | https://hdl.handle.net/1721.1/147837 |
Similar Items
-
Programming gene and engineered-cell therapies with synthetic biology
by: Kitada, Tasuku, et al.
Published: (2018) -
Engineered synthetic translational control for next generation mRNA gene therapies
by: Becraft, Jacob Robert.
Published: (2019) -
Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery
by: Endo, Kei, et al.
Published: (2017) -
In vitro and in vivo mRNA delivery using lipid-enveloped pHresponsive polymer nanoparticles
by: Su, Xingfang, et al.
Published: (2013) -
Engineering protein-protein devices for multilayered regulation of mRNA translation using orthogonal proteases in mammalian cells
by: Cella, Federica, et al.
Published: (2020)